Telisotuzumab (ABT-700) is a human recombinant bivalent antibody, a therapeutic antibody against the hepatocyte growth factor receptor (MET) that binds c-Met with high affinity and inhibits c-Met signaling. Telisotuzumab has antitumor activity.
Purity:
99.0%
CAS Number:
[1781223-80-0]
* VAT and and shipping costs not included. Errors and price changes excepted